Skip to main content

Articles

PharMerica and Onco360 Finalize Strategic Investment; Establish First National Oncology Pharmacy and Care Management Platform

Cost and Drug Utilization Patterns Associated with the Management of Rosacea

Skin Disorders the Number One Reason for Medical Visits in the United States

Fetzima Extended-Release Receives FDA Approval for the Treatment of Major Depressive Disorder in Adults

Simponi Aria: A New Intravenous TNF Inhibitor for the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis

Conference Correspondent

A Diagnostic Test for Lupus Based on DNA Methylation Signatures from Peripheral Blood Mononuclear Cells

Conference Correspondent

The Epidemiology of Systemic Lupus Erythematosus: Disease Prevalence and Impact on Employment and Work Productivity

Conference Correspondent

Pregnancy Complications in Lupus: Retrospective Observational Analysis from a US Health Claims Database

Conference Correspondent

Effects of Blisibimod on Renal and Inflammation Biomarkers and on Serum Immunoglobulin and Infection Risk in Patients with Lupus: Results from the PEARL-SC and Open-Label Extension Studies

Conference Correspondent

Safety and Efficacy of Epratuzumab in Patients with Lupus Confirmed in a Long-Term Open-Label Extension Study

Page 162 of 244
Results 1611 - 1620 of 2434